Carregant...
Efficacy and safety of biosimilar filgrastim in primary and secondary prevention of febrile neutropenia
Neutropenia and febrile neutropenia (FN) are among the most common side effects/complications of chemotherapy. The aim of the present study was to evaluate the practice of the use of biosimilar filgrastim in the primary and secondary prevention of FN, and assess its efficacy and safety. A multi-cent...
Guardat en:
| Publicat a: | Biomed Rep |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5526162/ https://ncbi.nlm.nih.gov/pubmed/28804626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2017.938 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|